NIH Funds UAB to Explore Vaccine for Gonorrhea Prevention

Researchers at University of Alabama at Birmingham (UAB) were awarded a grant by National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to explore the efficacy of the vaccine, Bexsero, in protecting against infection with bacteria that causes gonorrhea. Bexsero is already used to protect against meningitis. A “vaccine for this infection could enhance the reproductive and sexual health of millions of people globally. It’s really exciting,” said Jeanne Marrazzo, MD, MPH, director of UAB’s Division of Infectious Diseases and principal investigator of the study.

Learn more.

About Kim Rodgers

Kim Rodgers serves as a Communications Specialist at NACCHO. Her work includes promoting local health departments' best practices, as well as partner tools and resources, in infectious disease and preparedness through NACCHO's communications channels, storytelling, and outreach to various audiences.

Leave a Reply

Your email address will not be published. Required fields are marked *